Author

Kole DeGolier

National Jewish HealthORCID 0000-0002-4144-7277Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amanda Novak· 1 shared Christine R. Brzezinski· 1 shared Dimiter Dmitrov· 1 shared Lillie Leach· 1 shared Mark Eric KohleriD· 1 shared Terry J. FryiD· 1 shared Zachary H. WalshiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amanda Novak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintMar 13, 2025

Rational redesign of antigen binding domain improves in vivo efficacy of CD22-CAR T cells

Kole DeGolier, Zachary H. Walsh, Lillie Leach…·Terry J. Fry

This study improves the in vivo efficacy of CD22-targeted CAR T cells by optimizing the balance between binding affinity and tonic signaling through rational redesign of the antigen binding domain.

DOI 10.1101/2025.03.13.643183

humanexperimental assay

𝕏 PostBluesky